Position Summary

Lead the development, industrialisation, and lifecycle delivery of the assigned physical medicine (small molecule or oligonucleotide) from Commit to Phase 2 (C2P2) through to commercial launch, including global file preparation, launch readiness, and post‑launch lifecycle activities.

Responsibilities

• Engage with the medicine 6–12 months prior to C2P2 to prepare plans, resources, and budgets.
• Define the medicine development strategy and commercial vision with the Medicine Development Leader and team.
• Generate options and recommendations for Phase 3 (P3) development, supply, and global regulatory filings that balance time, cost, resources, and risk.
• Lead the execution of Product Performance Qualification (PPQ), Continuous Process Verification (CPV), and PAI readiness.
• Support global file, review, and launch readiness; oversee packaging, plus post‑launch needs and lifecycle projects.
• Communic...